Microbiology

  1. Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies

    1. Renhong Yan
    2. Ruoke Wang
    3. Bin Ju
    4. Jinfang Yu
    5. Yuanyuan Zhang
    6. Nan Liu
    7. Jia Wang
    8. Qi Zhang
    9. Peng Chen
    10. Bing Zhou
    11. Yaning Li
    12. Yaping Shen
    13. Shuyuan Zhang
    14. Long Tian
    15. Yingying Guo
    16. Lu Xia
    17. Xinyue Zhong
    18. Lin Cheng
    19. Xiangyang Ge
    20. Juanjuan Zhao
    21. Hong-Wei Wang
    22. Xinquan Wang
    23. Zheng Zhang
    24. Linqi Zhang
    25. Qiang Zhou

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Silicon Nitride Inactivates SARS-CoV-2 in vitro

    1. Caitlin W. Lehman
    2. Rafaela Flur
    3. Kylene Kehn-Hall
    4. Bryan J. McEntire
    5. B. Sonny Bal
    6. Ryan M. Bock

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Sequencing of SARS-CoV-2 genome using different nanopore chemistries

    1. Oscar González-Recio
    2. Mónica Gutiérrez-Rivas
    3. Ramón Peiró-Pastor
    4. Pilar Aguilera-Sepúlveda
    5. Cristina Cano-Gómez
    6. Miguel Ángel Jiménez-Clavero
    7. Jovita Fernández-Pinero

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. High titers of multiple antibody isotypes against the SARS-CoV-2 spike receptor-binding domain and nucleoprotein associate with better neutralization

    1. Maria G. Noval
    2. Maria E. Kaczmarek
    3. Akiko Koide
    4. Bruno A. Rodriguez-Rodriguez
    5. Ping Louie
    6. Takuya Tada
    7. Takamitsu Hattori
    8. Tatyana Panchenko
    9. Larizbeth A. Romero
    10. Kai Wen Teng
    11. Andrew Bazley
    12. Maren de Vries
    13. Marie I. Samanovic
    14. Jeffrey N. Weiser
    15. Ioannis Aifantis
    16. Joan Cangiarella
    17. Mark J. Mulligan
    18. Ludovic Desvignes
    19. Meike Dittmann
    20. Nathaniel R. Landau
    21. Maria Aguero-Rosenfeld
    22. Shohei Koide
    23. Kenneth A. Stapleford

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Development and pre-clinical characterization of two therapeutic equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19

    1. Guillermo León
    2. María Herrera
    3. Mariángela Vargas
    4. Mauricio Arguedas
    5. Andrés Sánchez
    6. Álvaro Segura
    7. Aarón Gómez
    8. Gabriela Solano
    9. Eugenia Corrales-Aguilar
    10. Kenneth Risner
    11. Aarthi Narayanan
    12. Charles Bailey
    13. Mauren Villalta
    14. Andrés Hernández
    15. Adriana Sánchez
    16. Daniel Cordero
    17. Daniela Solano
    18. Gina Durán
    19. Eduardo Segura
    20. Maykel Cerdas
    21. Deibid Umaña
    22. Edwin Moscoso
    23. Ricardo Estrada
    24. Jairo Gutiérrez
    25. Marcos Méndez
    26. Ana Cecilia Castillo
    27. Laura Sánchez
    28. José María Gutiérrez
    29. Cecilia Díaz
    30. Alberto Alape

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus

    1. Xufang Deng
    2. Yafang Chen
    3. Anna M. Mielech
    4. Matthew Hackbart
    5. Kristina R. Kesely
    6. Robert C. Mettelman
    7. Amornrat O’Brien
    8. Mackenzie E. Chapman
    9. Andrew D. Mesecar
    10. Susan C. Baker

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. New targets for drug design: importance of nsp14/nsp10 complex formation for the 3’‐5’ exoribonucleolytic activity on SARS‐CoV‐2

    1. Margarida Saramago
    2. Cátia Bárria
    3. Vanessa G. Costa
    4. Caio S. Souza
    5. Sandra C. Viegas
    6. Susana Domingues
    7. Diana Lousa
    8. Cláudio M. Soares
    9. Cecília M. Arraiano
    10. Rute G. Matos

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein

    1. Sylvie Roy
    2. Karim Ghani
    3. Pedro O. de Campos-Lima
    4. Manuel Caruso

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Molecular Characterization, Phylogenetic and Variation Analyzes of SARS-CoV-2 strains in Turkey

    1. Karamese Murat
    2. Ozgur Didem
    3. Tutuncu Emin Ediz

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium

    1. Jessica K. Fiege
    2. Joshua M. Thiede
    3. Hezkiel Arya Nanda
    4. William E. Matchett
    5. Patrick J. Moore
    6. Noe Rico Montanari
    7. Beth K. Thielen
    8. Jerry Daniel
    9. Emma Stanley
    10. Ryan C. Hunter
    11. Vineet D. Menachery
    12. Steven S. Shen
    13. Tyler D. Bold
    14. Ryan A. Langlois

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 167 of 255 Next